30 likes | 41 Views
<br><br><br>https://www.cmoapi.com/product/orlistat/<br><br>How long does Orlistat take to work<br>
E N D
How long does Orlistat take to work? Orlistat is a medicine which can help you to lose weight if you are overweight or obese. Orlistat works by blocking chemicals (enzymes) in your gut which digest fat. Nearly a third of the fat that you eat is blocked by orlistat. For Orlistat to work, it must be used in conjunction with other weight loss tactics. These include a regular exercise programme and a healthy diet plan. When taken on its own, Orlistat may not reduce weight, as it doesn't burn existing fat. Orlistat starts working the first time you take it. If you take Orlistat as directed and as part of a calorie-controlled diet and with regular exercise, you should start to see results within two weeks. Most weight loss as a result of Orlistat happens within the first six months of taking the medication.Orlistat works by blocking fat from being absorbed into the body after it is eaten during a meal. Approximately 5 to 10 pounds may be lost during the first 6 months of orlistat use. Eat regularly, don't skip meals. You will need to take one Orlistat three times per day immediately before, during, or up to 1 hour
following a meal. Cut down on portion sizes. Serve less at meal times by using a smaller plate, for example a tea plate, or give yourself a couple of spoonfuls less at each meal. Orlistat should be discontinued if weight loss <5% after the first 12 weeks or if the patient regains weight at any time whilst receiving drug treatment Orlistat blocks intestinal fat absorption by inhibiting gastric and pancreatic lipase and thus can cause symptoms such as rectal pain, oily feces, frequent defecation, nausea and vomiting. Orlistat has tolerable gastrointestinal side effects and no major drug toxicity.Orlistat could cause symptoms such as rectal pain, oily feces, frequent defecation, nausea and vomiting, Orlistat is a viable adjunct to lifestyle interventions used in the long-term management of obesity. Reference 1."FDA Drug Safety Communication: Completed safety review of Xenical/Alli (orlistat) and severe liver injury". fda.gov. 2. "Archived copy". Archived from the original on 31 August 2011. Retrieved 12 April 2011.
3. Douglas, Ian J; Julia Langham; Krishnan Bhaskaran; Ruth Brauer; Liam Smeeth (2013). "Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink". BMJ. 346: f1936. doi:10.1136/bmj.f1936. PMC 3624963. PMID 23585064. 4. Kolata, Gina (20 January 1999). "Obesity Drug Can Lead to Modest Weight Loss, Study Finds". The New York Times. Retrieved 11 December 2007. https://www.cmoapi.com/ https://www.cmoapi.com/product/orlistat/ https://www.facebook.com/Cmoapi-114510347044359/ https://www.pinterest.com/cmoapibiotech/boards/